PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.29%
Negative revenue growth while OR stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-0.43%
Negative gross profit growth while OR is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-0.43%
Negative EBIT growth while OR is at 67.63%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-0.43%
Negative operating income growth while OR is at 67.63%. Joel Greenblatt would press for urgent turnaround measures.
8.35%
Net income growth under 50% of OR's 101.98%. Michael Burry would suspect the firm is falling well behind a key competitor.
10.00%
EPS growth under 50% of OR's 101.94%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
10.00%
Diluted EPS growth under 50% of OR's 101.94%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.26%
Share change of 0.26% while OR is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.21%
Diluted share change of 0.21% while OR is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-61.46%
Dividend reduction while OR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-5.26%
Negative OCF growth while OR is at 26.31%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
29250.87%
FCF growth above 1.5x OR's 27.88%. David Dodd would verify if the firm’s strategic investments yield superior returns.
369.06%
10Y CAGR of 369.06% while OR is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
194.35%
5Y CAGR of 194.35% while OR is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
73.48%
3Y CAGR of 73.48% while OR is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
1883.30%
OCF/share CAGR of 1883.30% while OR is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
271.01%
OCF/share CAGR of 271.01% while OR is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
62.94%
3Y OCF/share CAGR of 62.94% while OR is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
1508.48%
10Y net income/share CAGR of 1508.48% while OR is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
165.13%
Net income/share CAGR of 165.13% while OR is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
7.72%
3Y net income/share CAGR of 7.72% while OR is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
3689.21%
Equity/share CAGR of 3689.21% while OR is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
157.40%
Equity/share CAGR of 157.40% while OR is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
62.48%
Equity/share CAGR of 62.48% while OR is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
58.62%
AR growth of 58.62% while OR is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
No Data
No Data available this quarter, please select a different quarter.
0.06%
Asset growth of 0.06% while OR is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
2.94%
BV/share growth of 2.94% while OR is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-9.00%
We’re deleveraging while OR stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-1.09%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.